AETHLON MEDICAL INC.
CEO: James A. Joyce.
Revenue: $1.36 million as of March 31, 2012; $ 0.00 as of March 31, 2011.
Net loss: $8.11 million as of March 31, 2012; $5.71 million as of March 31, 2011.
No. of local employees: Nine.
Headquarters: San Diego.
Year founded: 1999.
Stock symbol and exchange: AEMD on the OTC Bulletin Board.
Company description: It creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions.
Key factors for success: Hemopurifier commercialization, new contract awards, and the advancement of clinical research programs that support infectious disease and cancer indications.
Aethlon Medical Inc...